JB
At a glance
Clients
0
past 12 months
Filings
0
last filed Apr 2025
Agencies
0
contacted · past 12 months
Activity
filings by quarter
Background
Career
CH
Dates reflect our filing record (begins 2024); many tenures start earlier.
Government experience
House Energy and Commerce Committee
Disclosed on LD-2 filings
Specific issues
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
- Pharmaceutical Tariffs
- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0
- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act
H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments
Clients
No client work disclosed in the past 12 months.